Article examining preventing central line-associated bloodstream infections (CLABSI)


Intravenous literature: Dumont, C. and Nesselrodt, D. (2012) Preventing central line-associated bloodstream infections CLABSI. Nursing. 42(6), p.41-46.

Sample text:

Mortality for central line-associated bloodstream infections (CLABSIs) is 12% to 25%, making them among the most deadly of healthcare-associated infections (HAIs). CLABSIS are also expensive: the average cost per case is upwards of $26,000.1,2 The good news is that the incidence of CLABSI in ICU patients across the United States has been reduced from an estimated 43,000 in 2001 to 18,000 in 2009—a 58% reduction. The CDC estimates that this reduction represents 3,000 to 6,000 lives saved and a cost saving of $414 million in ICUs in 2009 alone.3 Better yet, some hospitals report zero CLABSIS in their ICUs.4So how did they make these improvements? By using best practices. This article presents the latest evidence-based recommendations for CLABSI prevention and discusses the implications for direct care nurses.

Click here for full text.

Main page


Comments are closed.